Evidence map›Paper›PMID 16225456›Full record

ArticleThe Biochemical journal2006

Extracellular NAD+ regulates intracellular calcium levels and induces activation of human granulocytes.

Santina Bruzzone, Iliana Moreschi, Lucrezia Guida, Cesare Usai, Elena Zocchi, Antonio De Flora

Open access · greenAbstract read
In one paragraph

Article in The Biochemical journal, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. NADNature cell biology · 2023
    Article
  4. Article
  5. Schistosoma mansoni and the purinergic halo.Trends in parasitology · 2022
    Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. NADFrontiers in molecular biosciences · 2021
    Review
  11. Review
  12. A population of CD4Clinical & translational immunology · 2020
    Article
  13. New mechanisms of phenytoin in calcium homeostasis: competitive inhibition of CD38 in hippocampal cells.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Scant Extracellular NAD Cleaving Activity of Human Neutrophils is Down-Regulated by fMLP via FPRL1.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2014
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Santina BruzzoneDepartment of Experimental Medicine, Section of Biochemistry, and Center of Excellence for Biomedical Research, University of Genova, Viale Benedetto XV/1, 16132 Genova, Italy.
Iliana Moreschi
Lucrezia Guida
Cesare Usai
Elena Zocchi
Antonio De Flora
University of Genoa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Beta-NAD+e (extracellular beta-NAD+), present at nanomolar levels in human plasma, has been implicated in the regulation of [Ca2+]i (the intracellular calcium concentration) in various cell types, including blood cells, by means of different mechanisms. Here, we demonstrate that micromolar NAD+e (both the alpha and the beta extracellular NAD+ forms) induces a sustained [Ca2+]i increase in human granulocytes by triggering the following cascade of causally related events: (i) activation of adenylate cyclase and overproduction of cAMP; (ii) activation of protein kinase A; (iii) stimulation of ADP-ribosyl cyclase activity and consequent overproduction of cADP-ribose, a universal Ca2+ mobilizer; and (iv) influx of extracellular Ca2+. The NAD+e-triggered [Ca2+]i elevation translates into granulocyte activation, i.e. superoxide and nitric oxide generation, and enhanced chemotaxis in response to 0.1-10 microM NAD+e. Thus extracellular beta-NAD+e behaves as a novel pro-inflammatory cytokine, stimulating human granulocytes and potentially recruiting them at sites of inflammation.

Indexed as

ADP-ribosyl CyclaseCalciumChemotaxisCyclic ADP-RiboseCyclic AMPCyclic AMP-Dependent Protein KinasesGranulocytesHumansNADNitric OxideRespiratory BurstSignal TransductionSuperoxidesADP-ribosyl CyclaseCalciumCyclic ADP-RiboseCyclic AMPCyclic AMP-Dependent Protein KinasesNADNitric OxideSuperoxides

Identifiers

PMID16225456
PMCPMC1360722
OpenAlexW2047135366

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.